scholarly journals Comparative analysis of first-line treatment regimens for advanced EGFR-mutant non-small cell lung cancer patients with stable brain metastases

2020 ◽  
Vol 9 (4) ◽  
pp. 2062-2071
Author(s):  
Lu Dai ◽  
Chun-Yue Luo ◽  
Guang-Xia Hu ◽  
Gang Chen ◽  
Chuan-Xin Wu ◽  
...  
Keyword(s):  
Lung Cancer ◽  
Comparative Analysis ◽  
Small Cell ◽  
Line Treatment ◽  
Small Cell Lung ◽  
First Line ◽  
Lung Cancer Patients ◽  
Treatment Regimens ◽  
Egfr Mutant ◽  
First Line Treatment

Survival Outcome of Inoperable Non-Small Cell Lung Cancer Patients Receiving Conventional Dose Epirubicin and Paclitaxel as First-Line Treatment

Oncology ◽  
2005 ◽  
Vol 68 (4-6) ◽  
pp. 350-355 ◽  
Author(s):  
Chih-Hsin Yang ◽  
Min-Chun Chen ◽  
Ann-Lii Cheng ◽  
Chih-Hung Hsu ◽  
Kun-Huei Yeh ◽  
...  
Keyword(s):  
Lung Cancer ◽  
Cancer Patients ◽  
Survival Outcome ◽  
Small Cell ◽  
Line Treatment ◽  
Small Cell Lung ◽  
First Line ◽  
Lung Cancer Patients ◽  
Conventional Dose ◽  
First Line Treatment

scholarly journals Bevacizumab, pemetrexed and carboplatin in first-line treatment of non-small cell lung cancer patients: Focus on patients with brain metastases

2016 ◽  
Vol 12 (6) ◽  
pp. 4635-4642 ◽  
Author(s):  
Dimitra Stefanou ◽  
Sofia Stamatopoulou ◽  
Antigoni Sakellaropoulou ◽  
Gavriil Akakios ◽  
Marina Gkiaouraki ◽  
...  
Keyword(s):  
Lung Cancer ◽  
Brain Metastases ◽  
Small Cell Lung Cancer ◽  
Cancer Patients ◽  
Small Cell ◽  
Line Treatment ◽  
Small Cell Lung ◽  
First Line ◽  
Lung Cancer Patients ◽  
First Line Treatment

TIGER 1: A randomized, open-label, phase 2/3 study of rociletinib (CO-1686) or erlotinib as first-line treatment for EGFR-mutant non-small cell lung cancer (NSCLC).

2015 ◽  
Vol 33 (15_suppl) ◽  
pp. TPS8108-TPS8108 ◽  
Author(s):  
D. Ross Camidge ◽  
Juergen Wolf ◽  
Jason B. Litten ◽  
Linda A Higashi ◽  
Jeffrey D. Isaacson ◽  
...  
Keyword(s):  
Lung Cancer ◽  
Small Cell ◽  
Line Treatment ◽  
Phase 2 ◽  
Small Cell Lung ◽  
First Line ◽  
Open Label ◽  
Open Label Phase ◽  
Egfr Mutant ◽  
First Line Treatment
Sign in / Sign up

Export Citation Format

Share Document